|
Garenoxacin
|
DB06160 |
[Garenoxacin, a quinolone antibiotic, is being investigated for the treatment of gram-positive and gram-negative bacterial infections.] |
|
2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL
|
DB07490 |
|
|
5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid
|
DB07491 |
|
|
Bromamphenicol
|
DB07492 |
|
|
5-Bromoindirubin
|
DB07493 |
|
|
(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE
|
DB07494 |
|
|
5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
|
DB07495 |
|
|
1,3-DIPHENYLUREA
|
DB07496 |
|
|
5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL
|
DB07497 |
|
|
4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID
|
DB07498 |
|
|
Indibulin
|
DB06169 |
|
|
N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide
|
DB07499 |
|
|
5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE
|
DB07280 |
|
|
N~3~-BENZYLPYRIDINE-2,3-DIAMINE
|
DB07281 |
|
|
3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid
|
DB07282 |
|
|
9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid
|
DB07283 |
|
|
N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE
|
DB07284 |
|
|
(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID
|
DB07285 |
|
|
BMS-564929
|
DB07286 |
[BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.] |
|
2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL
|
DB07287 |
|
